Holbrook Kerr's Form 4 filing
Avanos Medical, Inc. (AVNS) · filed Mar 10, 2025
- Accession no.
- 0001606498-25-000043
- Filed
- Mar 10, 2025
- Trade date
- Mar 6, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $106.8K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Holbrook KerrCIK 0001861246 | Officer (SVP, Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 6, 2025 | Common Stock | SSaleDisposed | −7,000 | $15.25 | −$106,750 | 82,047 | Direct | |
| Mar 6, 2025 | Common Stock | FTax withholdingDisposed | −2,474 | $15.30 | −$37,852.2 | 79,573 | Direct | |
| Mar 6, 2025 | Common Stock | FTax withholdingDisposed | −3,590 | $15.30 | −$54,927 | 75,983 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.